Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street
2026-03-09 10:20:00 ET
Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some investors and analysts now believe we are in an AI bubble ready to burst. Even if that's not the case, it's worth considering stocks in other industries that could offer excellent returns. Take Viking Therapeutics (NASDAQ: VKTX) , a biotech company looking to disrupt a fast-growing market.
Analysts believe this drugmaker is severely undervalued: Viking Therapeutics' average price target of $92.72 (according to Yahoo! Finance) implies an upside of about 181% from its current levels. Should investors purchase shares of Viking Therapeutics right now?
Image source: Getty Images.
NASDAQ: VKTX
VKTX Trading
4.92% G/L:
$34.97 Last:
1,506,929 Volume:
$33.50 Open:
